Psychiatry · Neurodevelopmental Disorders
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Diagnosis requires the presence of multiple motor tics and at least one vocal tic for more than one year.
Onset of symptoms must occur before the age of 18 years.
ADHD and Obsessive-Compulsive Disorder (OCD) are the most common comorbidities associated with Tourette disorder.
First-line pharmacological treatment for severe or impairing tics involves alpha-2 adrenergic agonists such as guanfacine or clonidine.
Antipsychotics like risperidone or aripiprazole are reserved for patients who fail initial therapy or have severe, refractory symptoms.
Comprehensive Behavioral Intervention for Tics (CBIT) is the preferred non-pharmacologic first-line therapy.
Pathophysiology involves dopaminergic dysregulation within the cortico-striato-thalamo-cortical (CSTC) circuits.
Vignette unlocked
A 9-year-old boy is brought to the clinic by his mother due to persistent, repetitive behaviors. For the past 14 months, he has frequently shrugged his shoulders and blinked his eyes excessively, accompanied by occasional grunting sounds in class. His teacher notes that he has significant difficulty staying on task and often fidgets, consistent with a diagnosis of ADHD. The patient is distressed by these movements, which occur multiple times a day. He has no history of medication use or illicit substance exposure.
What is the most appropriate first-line pharmacologic treatment for this patient's condition?
Guanfacine
The patient meets criteria for Tourette disorder (multiple motor tics, vocal tics, >1 year duration). Alpha-2 adrenergic agonists like guanfacine are the preferred first-line pharmacotherapy, especially in patients with comorbid ADHD.
Full handout
High yield triage
Etiology / Epidemiology
Onset before age 18; strong genetic component with male predominance.
Clinical Manifestations
Multiple motor tics and at least one phonic tic for >1 year.
Diagnosis
Clinical diagnosis; no specific lab or imaging required.
Treatment
Habit reversal therapy (HRT) is first-line; alpha-2 agonists (e.g., clonidine) for pharmacotherapy.
Prognosis
Most symptoms peak in early adolescence and improve by adulthood.
Full handout
Epidemiology & Etiology
Tourette disorder typically presents in childhood, with a mean onset of 6-7 years. It is significantly more common in males (3:1 ratio). A strong hereditary link exists, often manifesting as a spectrum of tic disorders within families.
Pertinent Anatomy
Dysfunction involves the basal ganglia, specifically the striatum and its connections to the frontal cortex. This corticostriato-thalamo-cortical circuit is critical for motor control and inhibition.
Pathophysiology
The disorder is characterized by a dopaminergic dysregulation within the basal ganglia. Excessive dopamine activity leads to the failure of inhibitory control over motor and vocal outputs. This results in the premonitory urge that precedes the involuntary tic.
Clinical Manifestations
Patients exhibit multiple motor tics (e.g., eye blinking, facial grimacing) and at least one phonic tic (e.g., grunting, coprolalia). Tics must persist for >1 year and occur many times a day. Red flags include sudden onset of tics in adulthood, which warrants investigation for secondary causes like Wilson disease or drug-induced states.
Diagnosis
Diagnosis is strictly clinical based on DSM-5 criteria. There is no gold standard biomarker or imaging test. Clinicians must rule out secondary causes such as PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections) if the onset is abrupt.
Treatment
Behavioral intervention, specifically Comprehensive Behavioral Intervention for Tics (CBIT), is the first-line treatment. If pharmacotherapy is required, alpha-2 adrenergic agonists (clonidine or guanfacine) are preferred due to a better side-effect profile than antipsychotics. Tardive dyskinesia is a risk with long-term use of antipsychotics (e.g., risperidone), which are reserved for severe, refractory cases.
Prognosis
Approximately 50% of patients experience significant symptom reduction by late adolescence. ADHD and OCD are the most common comorbidities, often causing more functional impairment than the tics themselves. Monitoring for these comorbid conditions is essential for long-term management.
Differential Diagnosis
PANDAS: abrupt onset following Group A Strep infection
Sydenham chorea: associated with rheumatic fever and carditis
Wilson disease: check ceruloplasmin and Kayser-Fleischer rings
Stereotypic movement disorder: repetitive, non-tic movements like rocking
Drug-induced tics: history of stimulant or antipsychotic use